Old Web
English
Sign In
Acemap
>
authorDetail
>
Jeffrey Riskin
Jeffrey Riskin
Georgetown University
Cancer
PD-L1
Chemistry
Transforming growth factor
Breast cancer
3
Papers
55
Citations
0.00
KQI
Citation Trend
Filter By
Interval:
1900~2024
1900
2024
Author
Papers (3)
Sort By
Default
Most Recent
Most Early
Most Citation
No data
Journal
Conference
Others
Abstract B43: Simultaneous inhibition of CXCR1/CXCR2, TGF-β, and PD-L1 overcomes immune resistance driven by tumor plasticity
2020
Lucas A. Horn
Jeffrey Riskin
Heidi A. Hempel
Hanne Lind
Kristen Fousek
Duane H. Hamilton
Kristen K. McCampbell
Jeffrey Schlom
Claudia Palena
Show All
Source
Cite
Save
Citations (0)
Simultaneous inhibition of CXCR1/2, TGF-beta, and PD-L1 remodels the tumor and its microenvironment to drive antitumor immunity.
2020
Journal for ImmunoTherapy of Cancer
Lucas A. Horn
Jeffrey Riskin
Heidi A. Hempel
Kristen Fousek
Hanne Lind
Duane H. Hamilton
Kristen K. McCampbell
Dean Y. Maeda
John A. Zebala
Zhen Su
Jeffrey Schlom
Claudia Palena
Show All
Source
Cite
Save
Citations (27)
Lifetime Genistein Intake Increases the Response of Mammary Tumors to Tamoxifen in Rats.
2017
Clinical Cancer Research
Xiyuan Zhang
Katherine L. Cook
Anni Wärri
Idalia Cruz
Mariana Rosim
Jeffrey Riskin
William G. Helferich
Daniel R. Doerge
Robert Clarke
Leena Hilakivi-Clarke
Show All
Source
Cite
Save
Citations (28)
1